Mood, serotonin and social interactio
- Conditions
- DepressionMood disorder10027946
- Registration Number
- NL-OMON36285
- Lead Sponsor
- Rijksuniversiteit Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Age 18-65 years. At least one first-degree family member with MDD (FH+) or no first- and second-degree family members with MDD (FH-). Willingness to cooperate; to sign written informed consent.
Any current or past DSM-IV Axis I mood disorder, anxiety disorder, psychotic disorder, eating disorder, or somatoform disorder as determined by SCID-NP interview. Any current substance use disorder. Any past substance dependence. Ongoing medical treatment for a chronic disease, particularly cancer, gastrointestinal disease, phenylketonurea, diabetes, cardiovascular disease, or disease of the liver or kidneys. Not speaking Dutch fluently. Current or past use of neuroleptics, sedative drugs, antidepressants etc. On test days, a positive urine test for drugs of abuse. For women, initiation of hormonal contraceptive treatments <= 3 months prior to screening, or a positive urine test for pregnancy on test days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary outcome is empathic accuracy measured with an empathic accuracy task<br /><br>(EAT). </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome measures are the amount of behavioural mimicry, speech<br /><br>characteristics, heart rate variability (HRV), scores on the Positive and<br /><br>Negative Affect Schedule (PANAS) and Visual Analogue Scale (VAS). Finally,<br /><br>polymorphisms of genes thought to be related to MDD are analysed.</p><br>